News & Updates

The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.

Urban environmental determinants of vitamin D status, such as air pollution and sun exposure, appear to be important factors in assessing the risk of mortality from COVID-19, reports a recent study.

Chronic obstructive pulmonary disease (COPD) patients initiating treatment with a long-acting muscarinic antagonist (LAMA) plus a long-acting β2-agonist (LABA) tend to have higher disease severity than those who are started on LAMA, according to real-world data from Singapore. However, there are as many patients who experience clinical worsening in the LAMA group as there are in the LAMA+LABA group.

There are currently 40 approved vaccines against COVID-19, of which 11 have been granted Emergency Use Authorization by the World Health Organization. [covid19.trackvaccines.org/vaccines/approved] With over 300 other candidates in the development pipeline – over 100 of which are in clinical testing [vac-lshtm.shinyapps.io/ncov_vaccine_landscape] – are new vaccines necessary?

Isolated bronchiectasis (BR) in rheumatoid arthritis (RA) that is not caused by interstitial lung disease (ILD) is associated with seropositivity, older age at RA diagnosis, and lower body mass index (BMI) at RA onset, a recent study has found.

Adults with good cardiorespiratory fitness, estimated by a nonexercise algorithm, have a lower risk of developing hypertension, suggests a study.

In the treatment of COVID-19 inpatients, intravenous administration of dexamethasone leads to a shorter hospital stay compared with methylprednisolone, according to a study.